Expert consensus: Indication criteria and screening strategy for preeclampsia using the serum sFlt-1/PlGF ratio at 18–36 weeks of gestation in women at imminent/basal risk of preeclampsia under insurance coverage

ratio of tyrosine to placental growth factor (sFlt-1/PlGF ratio), a flow diagram for the short-term prediction of preeclampsia (PE) using the sFlt-1/PlGF ratio in women at imminent/basal risk of preeclampsia. sFlt-1/PlGF flow for PE using ratio in at risk of PE at of consensus of at Web Meeting” held on expert consensus, appropriate perinatal care under close observation is recommended for women at imminent/basal risk of PE who have an sFlt-1/PlGF ratio > 38 at recruitment. For women at imminent risk of PE who have an sFlt-1/PlGF ratio ≤ 38 at recruitment, shortening the interval between maternal check-ups is recommended, along with re-evaluation of the sFlt-1/PlGF ratio 1–4 weeks after initial blood sampling, based on patient/fetal condition. using the sFlt-1/PlGF ratio under insurance in at of and